Mesa Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 75 to 82.
Over the last 7 days, the United States market has risen by 4.0%, contributing to a remarkable 39% increase over the past year, with earnings projected to grow by 16% annually in the coming years. In ...